ArticleTargeted oncology2026

Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database.

Lena Dreikhausen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.